Promotional Review Objectives, Utilizing Social Media, and Incorporating Compliance Software Among Session Topics
March 11, 2014 (Newswire.com) - The first-ever Compliant Advertising and Promotion of Healthcare Products Conference will take place April 10-11, 2014 in Alexandria, Virginia, fulfilling a demand for an inclusive device and pharmaceutical focused meeting that covers both regulatory and promotional review committee topics.
Session topics include increasing awareness of evidence to support claims, DPLC insight, implications of mobile medical applications guidance, and utilizing social media as an advertising medium. The conference, hosted by Q1 Productions, will provide delegates with numerous networking opportunities and educational sessions and panel discussions from nearly two dozen industry experts including Jill Charbonneau of Baxter Healthcare, Paul Swift of BD Diagnostics, and James Burrus of Johnson & Johnson.
"This conference is focused both in its scope and the industry segment it serves. Accordingly, the content is highly relevant and participants are afforded access to not only speakers, but other attendees as well," said Swift. "The dynamic facilitates a cordial exchange of information that I have found valuable."
The conference is the only promotional meeting of its kind that includes both pharmaceutical and medical device topics, fostering collaboration to inspire innovation within the healthcare industry. With a variety of case studies and interactive sessions on the agenda, attendees will be given more opportunities for networking through a more intimate peer-to-peer environment.
For more information or to register for the Compliant Advertising and Promotion of Healthcare Products Conference, or any other Q1 Productions events, please visit: www.q1productions.com/adpromo
Follow on twitter: @q1productions #q1adpromo
About the Organizer
Q1 Productions designs and develops webinars, training courses, conference programs and forums aimed at specifically targeted audiences throughout highly regulated industries in order to provide strategic learning and timely program content. Through a highly structured production process focused on research calls with end-users and key stakeholders in the industry, our team is able to understand the immediate business concerns of today's leading executives. Whether focusing on new or pending legislative and health policy issues or enhanced technologies or processes that will